1 completed, 1 enrolling by invitation. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Enrolling by invitation 1 |
| Phase 2 | 2 | Completed 1, Enrolling by invitation 1 |
Follow Tuberculosis, Central Nervous System: new trials by email Literature Review of Tuberculosis, Central Nervous System trials Research Report on Tuberculosis, Central Nervous System
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis Contezolid, Linezolid (LZD) - Tuberculosis, Meningitis | Phase 1 / Phase 2 | Enrolling by invitation | Beijing Chest Hospital | 24 | 2024-02-01 | 2025-02-06 |
| Optimizing Treatment to Improve TBM Outcomes in Children High-dose: RIF, INH, PZA, EMB, High dose: RIF, INH, PZA, LEVO, Standard of care: RIF, INH, PZA, EMB - Tuberculosis, Meningeal | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 38 | 2017-02-22 | 2021-10-28 |
Tuberculosis, Meningeal (2) · Meningitis (1) · Tuberculosis (1)
Actinomycetales Infections (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Central Nervous System Bacterial Infections (2) · Central Nervous System Diseases (2) · Central Nervous System Infections (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Meningitis, Bacterial (2) · Mycobacterium Infections (2) · Nervous System Diseases (2) · Neuroinflammatory Diseases (2) · Tuberculosis, Extrapulmonary (2) · Meningitis (1)
Control Groups (1) · Isoniazid (1) · Levofloxacin (1) · Linezolid (1) · NSC 366140 (1) · Rifampin (1) · contezolid (1)
Beijing Chest Hospital (1) · Johns Hopkins University (1)
China (1) · India (1) · Malawi (1)
R01HD074944 (1)